News | December 15, 2022
Kerala Ayurveda receives US patent for its herbal formulation
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
40,000 visitors and representatives of more than 80 countries set to visit the show
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
The conference is also expected to pave the way for nations to come out with bold and specific political commitments in the 2024 UN General Assembly High-Level Meeting on AMR
The company posted net profit of Rs.81.33 crores for the quarter ended September 30, 2021.
The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022
Subscribe To Our Newsletter & Stay Updated
